Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

ISR's Scott Page says diverse teams produce optimal results

Bound, Geronimus, et al. find estimates of decreasing longevity among low-SES whites sensitive to measures and interpretations

Thompson casts doubt on the rehabilitative intentions of prison labor

More News

Highlights

Seefeldt discusses her book Abandoned Families, Wed, March 29, 4 PM, Annenberg Auditorium

U-M participants at PAA Annual Meeting, April 27-29

Heather Ann Thompson wins Bancroft Prize for History for 'Blood in the Water'

Michigan ranks in USN&WR top-10 grad schools for sociology, public health, labor economics, social policy, social psychology

More Highlights

Next Brown Bag

Mon, April 10, 2017, noon:
Elizabeth Bruch

Race, Ethnicity, and Shared Decision Making for Hyperlipidemia and Hypertension Treatment: The DECISIONS Survey

Publication Abstract

Ratanawongsa, Neda, Brian J. Zikmund-Fisher, Mick P. Couper, John Van Hoewyk, and Neil R. Powe. 2010. "Race, Ethnicity, and Shared Decision Making for Hyperlipidemia and Hypertension Treatment: The DECISIONS Survey." Medical Decision Making, 30(Suppl. 5): 65S-76S.

Background. Racial/ethnic differences in shared decision making about cardiovascular risk-reduction therapy could affect health disparities. Objective. To investigate whether patient race/ethnicity is associated with experiences discussing cardiovascular risk-reduction therapy with health care providers. Setting. National sample of US adults identified by random-digit dialing. Design. Cross-sectional survey conducted in November 2006 to May 2007. Participants. Among participants in the National Survey of Medical Decisions (DECISIONS), a nationally representative sample of English-speaking US adults aged 40 and older, the authors analyzed respondents who reported discussing hyperlipidemia or hypertension medications with a health care provider in the previous 2 years. Measurements. In multivariate linear and logistic regressions adjusting for age, gender, income, insurance status, perceived health, and current therapy, they assessed the relation between race/ethnicity (black/Hispanic v. white) and decision making: knowledge, discussion of pros and cons of therapy, discussion of patient preference, who made the final decision, preferred involvement, and confidence in the decision. Results. Of respondents who discussed high cholesterol (N = 738) or hypertension (N = 745) medications, 88% were white, 9% black, and 4% Hispanic. Minorities had lower knowledge scores than whites for hyperlipidemia (42% v. 52%, difference -10% [95% confidence interval (CI): 15, -5], P < 0.001), but not for hypertension. For hyperlipidemia, minorities were more likely than whites to report that the health care provider made the final decision for treatment (31.7% v. 12.3% whites, difference 19.4% [95% CI: 6.9, 33.1%], P < 0.01); this was not true for hypertension. Limitations. Possible limitations include the small percentage of minorities in the sample and potential recall bias. Conclusions. Minorities considering hyperlipidemia therapy may be less informed about and less involved in the final decision-making process.

DOI:10.1177/0272989X10378699 (Full Text)

Country of focus: United States of America.

Browse | Search : All Pubs | Next